IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

[1]  M. Seibold,et al.  Lipid abnormalities in atopic skin are driven by type 2 cytokines. , 2018, JCI insight.

[2]  D. Hohl,et al.  Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in Infancy. , 2017, The Journal of investigative dermatology.

[3]  L. Engstrand,et al.  The role of the skin microbiome in atopic dermatitis: a systematic review , 2017, The British journal of dermatology.

[4]  A. Dattola,et al.  The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins , 2017, Scientific Reports.

[5]  T. Mustelin,et al.  The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies , 2017, The British journal of dermatology.

[6]  G. Yancopoulos,et al.  Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial , 2017, The Lancet.

[7]  Donald Y M Leung,et al.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. , 2017, The Journal of allergy and clinical immunology.

[8]  M. Suárez-Fariñas,et al.  An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. , 2017, The Journal of investigative dermatology.

[9]  K. Hood,et al.  Oral and Topical Antibiotics for Clinically Infected Eczema in Children: A Pragmatic Randomized Controlled Trial in Ambulatory Care , 2017, The Annals of Family Medicine.

[10]  P. Dorrestein,et al.  Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis , 2017, Science Translational Medicine.

[11]  R. Geha,et al.  Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression. , 2016, The Journal of investigative dermatology.

[12]  S. Pasmans,et al.  Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta‐analysis , 2016, The British journal of dermatology.

[13]  J. Silverberg,et al.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. , 2016, The New England journal of medicine.

[14]  C. Akdis,et al.  Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. , 2016, The Journal of allergy and clinical immunology.

[15]  Dan Knights,et al.  Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies , 2016, Nature Biotechnology.

[16]  K. Stone,et al.  Transplantation of human skin microbiota in models of atopic dermatitis. , 2016, JCI insight.

[17]  E. R. Sutherland,et al.  Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial , 2016, The Lancet.

[18]  William A. Walters,et al.  Improved Bacterial 16S rRNA Gene (V4 and V4-5) and Fungal Internal Transcribed Spacer Marker Gene Primers for Microbial Community Surveys , 2015, mSystems.

[19]  G. Yancopoulos,et al.  Targeting key proximal drivers of type 2 inflammation in disease , 2015, Nature Reviews Drug Discovery.

[20]  C. Flohr,et al.  Biomarkers for atopic dermatitis: a systematic review and meta-analysis , 2015, Current opinion in allergy and clinical immunology.

[21]  R. Gallo,et al.  The Role of the Skin Microbiome in Atopic Dermatitis , 2015, Current Allergy and Asthma Reports.

[22]  J. Faergemann,et al.  A retrospective analysis of skin bacterial colonisation, susceptibility and resistance in atopic dermatitis and impetigo patients. , 2015, Acta dermato-venereologica.

[23]  H. Kong,et al.  Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis. , 2015, Immunity.

[24]  G. Yancopoulos,et al.  Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.

[25]  D. Leung,et al.  Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. , 2014, The Journal of allergy and clinical immunology.

[26]  R. Knight,et al.  The Earth Microbiome project: successes and aspirations , 2014, BMC Biology.

[27]  T. Bieber,et al.  Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. , 2014, The New England journal of medicine.

[28]  F. Alt,et al.  Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes , 2014, Proceedings of the National Academy of Sciences.

[29]  L. Macdonald,et al.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice , 2014, Proceedings of the National Academy of Sciences.

[30]  S. Feldman,et al.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. , 2014, Journal of the American Academy of Dermatology.

[31]  Hélène Touzet,et al.  SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data , 2012, Bioinform..

[32]  Julia Oh,et al.  Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis , 2012, Genome research.

[33]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[34]  Eric P. Nawrocki,et al.  An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea , 2011, The ISME Journal.

[35]  U. Sivaprasad,et al.  Th2 Cytokines and Atopic Dermatitis. , 2011, Journal of clinical & cellular immunology.

[36]  M. Boguniewicz,et al.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation , 2011, Immunological reviews.

[37]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[38]  A. Hofman,et al.  Role of Staphylococcus aureus nasal colonization in atopic dermatitis in infants: the Generation R Study. , 2009, Archives of pediatrics & adolescent medicine.

[39]  Jonathan Hadgraft,et al.  Epidermal barrier dysfunction in atopic dermatitis. , 2009, The Journal of investigative dermatology.

[40]  J. Carucci,et al.  Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.

[41]  M. Boguniewicz,et al.  Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. , 2008, Clinical immunology.

[42]  M. Boguniewicz,et al.  The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. , 2007, The Journal of investigative dermatology.

[43]  B. Zhao,et al.  Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double‐blind multicentre randomized controlled trial , 2006, The British journal of dermatology.

[44]  H. Horz,et al.  Evaluation of Universal Probes and Primer Sets for Assessing Total Bacterial Load in Clinical Samples: General Implications and Practical Use in Endodontic Antimicrobial Therapy , 2005, Journal of Clinical Microbiology.

[45]  W. Fridman,et al.  CC Chemokine Ligand 18, An Atopic Dermatitis-Associated and Dendritic Cell-Derived Chemokine, Is Regulated by Staphylococcal Products and Allergen Exposure1 , 2004, The Journal of Immunology.

[46]  R. Thomson,,et al.  Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. , 2004, The Journal of molecular diagnostics : JMD.

[47]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[48]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[49]  E. Gelfand,et al.  Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model. , 2001, The Journal of investigative dermatology.

[50]  J. Leyden,et al.  Staphylococcus aureus in the lesions of atopic dermatitis , 1974, The British journal of dermatology.

[51]  J. Silverberg,et al.  Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis , 2019, The Journal of allergy and clinical immunology.

[52]  D. Leung,et al.  Immunologic, microbial, and epithelial interactions in atopic dermatitis. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[53]  K. Barnes,et al.  Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2009, The Journal of allergy and clinical immunology.

[54]  Thomas Bieber,et al.  Atopic dermatitis. , 2008, The New England journal of medicine.